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Abstract
Background: Acetaminophen (APAP) overdose causes acute liver failure (ALF) in animals and humans via the rapid
depletion of intracellular glutathione (GSH) and the generation of excess reactive oxygen species (ROS) that damage
hepatocytes. Stem cell therapy is a potential treatment strategy for ALF.
Methods: We isolated mesenchymal stem cells (MSCs) from mice omentum adipose tissue-derived stem cells (ASCs)
and transplanted them into a mouse model of APAP-induced ALF to explore their therapeutic potential. In addition,
we performed in vitro co-culture studies with omentum-derived ASCs and primary isolated hepatocytes to demonstrate
the hepatoprotective effect of omentum-derived ASCs on hepatocytes that were subjected to APAP-induced damage.
Result: ASC transplantation significantly improved the survival rate of mice with ALF and attenuated the severity of
APAP-induced liver damage by suppressing cytochrome P450 activity to reduce the accumulation of toxic nitrotyrosine
and the upregulation of NF-E2-related factor 2 (Nrf2) expression, resulting in an increase in the subsequent antioxidant
activity. These effects protected the hepatocytes from APAP-induced damage through the suppression of downstream
MAPK signal activation and inflammatory cytokine production.
Conclusions: our results demonstrate that omentum-derived ASCs are an alternative source of ASCs that regulate the
antioxidant response and may represent a beneficial therapeutic strategy for ALF.
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Background
Acetaminophen (APAP) is an effective analgesic and anti-
pyretic drug, but it can cause severe liver damage. APAP
overdose can result in liver failure, and it is a common
cause of acute liver failure (ALF) in Western countries [1].
APAP toxicity is controlled by cytochrome P450, particu-
larly cytochrome P450 subfamily 2E1 (CYP2E1), through
the formation of N-acetyl-p-benzoquinoneimine (NAPQI),
a highly reactive intermediary and toxic metabolite. This
compound subsequently induces oxidative stress and cova-
lently binds to liver proteins, causing cell death and dys-
function. At therapeutic doses, NAPQI conjugates with
intracellular glutathione (GSH) and is excreted from
the kidney. However, APAP overdose leads to increased
NAPQI production, the rapid depletion of GSH and
peroxynitrite formation [2]. Excessive NAPQI forma-
tion can trigger cell damage via an imbalance in oxida-
tive stress involving high levels of reactive oxygen
species (ROS), such as superoxide (O2
−), hydroxyl radi-
cals (OH·), and peroxynitrite, and it leads to low levels
of antioxidant enzymes, such as superoxide dismutase
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(SOD), glutathione peroxidase (GPx), and catalase. Anti-
oxidant defenses can scavenge the excess ROS. For ex-
ample, SOD can convert O2
− into H2O2 and then further
convert H2O2 into H2O and O2 by GPx and catalase [3].
Consequently, GSH can prevent the covalent binding of
toxic metabolites and suppress oxidative stress, which is a
potential approach to attenuate APAP toxicity and pro-
mote tissue repair/regeneration.
Growing evidence shows that mesenchymal stem cell
(MSC) therapy offers advantages for tissue repair and re-
generation in animal and clinical studies, based on its
immunomodulatory, anti-inflammatory and anti-fibrosis
effects and its effects on homing [4]. Adipose tissues
have recently been considered as a potential ideal source
of MSCs for clinical application because of the minim-
ally invasive procedures needed for collection, the ability
to harvest large quantities and their higher potential
immunomodulation and anti-inflammatory functions
compared with those of other sources [5]. In addition,
adipose tissue-derived stem cells (ASCs) exert protective
effects and antioxidant properties, enhancing tissue re-
pair and regeneration in animal models of kidney [6]
and liver failure [7]. However, the subsequent mecha-
nisms underlying the antioxidant effects and the poten-
tial survival benefits are not fully understood. The
omentum is the primary and largest intraperitoneal res-
ervoir of adipose tissue. This tissue can be harvested
easily during abdominal surgery, and it is even available
through a minimally invasive surgery approach. The omen-
tum is therefore a potential source of ASCs; however, the
therapeutic potential of omentum-derived ASCs has not
yet been evaluated in a disease model. The purpose of this
study is to characterize omentum-derived ASCs and to de-
termine whether the transplantation of omentum-derived
ASCs exerts therapeutic effects on mice with APAP-
induced acute liver failure.
Methods
Animals
C57BL/6 mice (male, ~6–8 weeks old) were used as cell
donors (hepatocytes and ASCs) and to establish an ALF
mouse model for transplantation. All animals were pur-
chased from the National Laboratory Animal Center in
Taipei, Taiwan. The mice were housed and handled in ac-
cordance with the ethical guidelines for laboratory animal
care of the National Taiwan University College of Medi-
cine, and the procedures were approved by the Institu-
tional Animal Care and Use Committee.
Cells
Mouse hepatocytes were isolated using a 2-step collage-
nase perfusion method as previously described [8]. ASCs
were isolated from mouse omentum adipose tissue, which
was cut into small pieces and digested in 0.5 units/ml of
collagenase type I (Life Technologies, Paisley, UK) for one
hour at 37 °C. After centrifugation at 1500 rpm for 5 min,
the pellet was resuspended with PBS (Corning, NY, USA)
and seeded into minimum essential medium eagle-alpha
modification (α-MEM) supplemented with 1 × antibiotic
(Invitrogen, NY, USA) and 10 % fetal bovine serum (FBS,
SBI Biological Industries, Belt Haemak, Israel). After 24 h
of incubation, the cells were washed with phosphate-
buffered saline (PBS), and then the medium was replaced
with fresh medium. For all experiments, the cells were
used after 3–7 passages and the medium was changed
every 3 days. For ASC characterization, the cells were
stained with CD31-PE-CY7, CD34-FITC, CD44-PE,
CD90-PE (BD Pharmingen, San Diego, CA, USA),
CD105-PE (eBioscience, San Diego, CA, USA), and
CD29-FITC (BioLegend, San Diego, CA, USA) and then
analyzed by flow cytometry (all antibodies were diluted
1:100 with PBS containing 2 % FBS). To evaluate the
cell differentiation ability, adipogenic and osteogenic
assays were modified according to Sotiropoulon et al.
[9]. To evaluate hepatogenic differentiation, the cells
were cultured in α-MEM containing 20 ng/ml epidermal
growth factor (EGF) and 10 ng/ml fibroblast growth factor
(FGF; PeproTech, Rocky Hill, NJ, USA) for 2 days; the
medium was then replaced with α-MEM containing 20 ng/
ml hepatocyte growth factore (HGF; PeproTech) and
4.9 mM nicotinamine (Sigma-Aldrich, St Louis, MO, USA)
for 1 week, followed by treatment with 20 ng/ml oncos-
tatin M (PeproTech), 1 μmol/L dexamethasone (Sigma-
Aldrich), and 50 mg/mL insulin-transferrin-selenium
(ITS; Gibco, Paisley, UK) that was prepared in α-MEM
for 1 week. Glycogen storage was measured by periodic
acid-Schiff (PAS) staining (Sigma-Aldrich) [10].
Acute liver failure model and omentum-derived ASC
treatment
Acute liver failure was induced in 8-week-old male
C57BL/6 mice. APAP (Sigma-Aldrich) was prepared in
saline at 70 °C and maintained in a water bath at 37 °C.
Mice were fasted overnight and treated with APAP
(600 mg/ kg, intraperitoneally) then randomly divided
into two groups: one group was infused with PBS
(100 μl/mouse), and the other group was infused with
omentum-derived ASCs (106/100 μl/mouse) via tail
vein injection at 30 min after APAP treated. For sur-
vival, the mice were monitored by 168 h (20 mice/
group); At 6 and 24 h after omentum-derived ASCs
with/without infusion (10 mice/group) , liver tissue and
serum were collected and stored at −80 °C. The liver
enzyme (glutamate-oxaloacetate transaminase, GOT;
glutamic-pyruvic transaminase, GPT) were evaluated by
the Laboratory Animal Center of National Taiwan Uni-
versity Medicine.
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Immunohistology
Liver tissue was fixed in 10 % formaldehyde (Sigma-
Aldrich), dehydrated, embedded in paraffin blocks, and
sectioned into 5 μm slices. The sections were stained with
hematoxylin and eosin (H&E; Sigma-Aldrich) for hist-
ology, and the necrosis grade was evaluated in 20 random
100 × images per animal, as described by Liu et al. [11] as
follows: “0” indicated normal; “1” indicated necrotic cells
in the first cell layer adjacent to the central vein; “2” indi-
cated necrotic cells extending two to three cell layers from
the central vein; “3” indicated necrotic cells extending
three to six layers from the central vein; “4” indicated nec-
rotic cells extending three to six layers and from one cen-
tral vein to another; and “5” indicated necrotic cells
throughout the section. The sections were deparaffinized
and dehydrated for immunohistology, and the endogenous
peroxide was inactivated with 3 % hydrogen peroxidase
(Sigma-Aldrich). The sections were then blocked with 3 %
normal goat serum (DAKO, Glostrup, Denmark) for 1 h,
stained with primary antibodies against cytochrome P450
subfamily 2E1 (1:200), 4-hydroxynonenal (1:200, Abcam,
Cambridge, MA, USA), or nitrotyrosine (1:50, clone
2A8.2, Millipore, Bedford, MA, USA) for 1 h at 37 °C and
then incubated with an horseradish peroxidase (HRP)-de-
tection kit (REALTM EnVision, DAKO) according to the
manufacturer’s protocol.
Antioxidant enzyme activity assay and GSH content
measurement
The activity of the antioxidant enzymes (SOD, GPx, and
catalase) and the GSH content were measured according
to the manufacturer’s protocol (BioVision, Palo Alto,
CA, USA). In brief, the liver tissues from the APAP
treatment and the omentum-derived ASC transplant-
ation groups were lysed in PBS by sonication, and the
supernatants were collected by centrifugation. For the in
vitro experiments, hepatocytes (105) that had been
treated with 15 mM APAP were grown in the lower
chambers of a six-transwell plate (0.4 μm pore size; BD,
Bioscience, San Jose, CA, USA), and omentum-derived
ASCs (105) were added to the upper chambers. Twenty-
four hours later, the hepatocytes were washed and lysed,
and the lysate was collected by centrifugation.
Western blot
Total proteins were extracted in lysis buffer (300 mM
NaCl, 50 mM HEPES pH 7.6, 1.5 mM MgCl2, 10 % gly-
cerol, 1 % Triton X-100, 10 mM NaPyrPO4, 20 mM NaF,
1 mM EGTA, 0.1 mM EDTA, 1 mM DTT, 1 mM PMSF,
and 1 mM Na4VO3) containing phosphatase inhibitors (all
were purchased from Sigma-Aldrich), quantified by protein
assay (Bio-Rad, Hercules, CA, USA), separated by 10 %
SDS-PAGE (Bio-Rad) and transferred to PVDF membranes
(Millipore). After being blocked with 5 % bovine serum
albumin (Sigma-Aldrich) in TBS buffer (50 mM Tris–HCl,
150 mM NaCl pH 7.2) with 0.1 % Tween (Sigma-Aldrich)
overnight, the membrane was incubated with primary
antibody overnight at 4 °C (JNK, phospho-JNK, ERK,
phospho-ERK, p38, and phospho-p38 were purchased from
Cell Signaling Technology, Danvers, MA, USA 1:2000;
cytochrome P450 subfamily 2E1 and 4-hydroxynonenal
were purchased from Abcam, 1:1000; and nitrotyrosine and
actin were purchased from Millipore at 1:500 and 1:3000,
respectively), followed by HRP-conjugated secondary anti-
body (1:10000, Jackson ImmunoResearch Laboratories,
West Grove, PA, USA) for 1 h at room temperature. The
protein intensity was detected with electrochemilumines-
cence (ECL) reagent (Millipore) according to the manufac-
turer’s protocol. The western blot band intensity was
quantified with the ImageJ software according to the manu-
facturer’s instructions.
Real-time quantitative PCR
Total RNA was extracted from liver tissue with a Direct-
XolTM RNA MiniPrep kit (Zymo Research, CA, USA). Re-
verse transcription was performed with an iScriptTM
cDNA Synthesis kit (Bio-Rad). Q-PCR was performed by
using an iCycler real-time detection system and SYBR
Green Supermix system (Bio-Rad) according to the manu-
facturer’s protocol. The primer sequences are provided in
Table 1. The relative mRNA levels were determined by Q-
PCR and normalized to GAPDH.
ROS, viability and LDH assays
For the ROS assays, the primary hepatocytes were seeded
in a 96-well plate (Corning) and treated with various con-
centrations of APAP (0, 5, 10, 15, 20, and 40 mM) for
24 h. CellROX Deep Red reagent (Life Technologies) was
added 30 min before the end point and then washed out
with PBS. The ROS intensities were determined by using
an ELISA reader (Ex/Em: 644/655 nm, BioTek, Instru-
ments, Inc., Winooski, VT). Cell viability was assessed by
the MTT assay (Sigma-Aldrich). Cytotoxicity was deter-
mined using the LDH activity assay (BioVision) according
to the manufacturer’s instructions.
Statistical analysis
Values are presented as means ± SEM. Student’s paired
t-test or one-way ANOVA followed by Tukey’s test was
used for between-group comparisons of the means. The
survival analysis was assessed with the SigmaStat soft-
ware, version 3.5 (Chicago, IL, USA); other analyses were
performed with the GraphPad InStat software, version 3
(San Diego, CA, USA). All directional P values were 2-
tailed, and a value of .05 or less was considered signifi-
cant for all tests.
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Result
Characterization of omentum adipose tissue-derived stem
cells (omentum-derived ASCs)
We acquired ASCs from mouse omentum tissue by colla-
genase digestion. These cells presented fibroblast-like cell
morphology and expressed various stem cell markers, in-
cluding CD29, CD90, CD105, and CD44. The ASCs were
negative for CD31 and CD34 (Fig. 1A). We subsequently
applied lineage-specific induction factors to assess the dif-
ferentiation ability of mouse omentum-derived ASCs. The
mouse omentum-derived ASCs differentiated into adipo-
cytes, as demonstrated by Oil Red O staining (Fig. 1B1),
and osteoblasts, as demonstrated by alizarin staining
(Fig. 1B3) after two weeks of induction. Moreover, these
cells also differentiated into hepatocytes, as shown by
PAS staining, after induction with hepatogenic medium
for 16 days (Fig. 1B2). Therefore, the cells that were de-
rived from mouse omentum tissue expressed specific
surface markers for MSCs and possessed multi-lineage
differentiation ability. These results indicate that omen-
tum is an alternative source to obtain ASCs for subse-
quent studies or therapy.
Omentum-derived ASCs protect against APAP-induced
liver injury and improve the survival rate of mice with
acute liver failure
To explore the therapeutic effects of omentum-derived
ASCs on ALF, we used the ALF mouse model induced by
APAP. Eight of 20 mice were died within 24–72 h after
600 mg/kg of APAP injection (60 % of survival rate), only
10 % of mice were died after omentum-derived ASC treat-
ment (90 % of survival rate vs. control group). The overall
differenece in survival rate between groups with and with-
out omentum-derived ASC was significant (P ≤ 0.01,
Fig. 2A). The severity of APAP-induced liver damage was
evaluated by measuring the plasma liver enzyme level and
histological necrosis score at 6 and 24 h after APAP injec-
tion. The plasma GPT level decreased significantly at both
time points after treatment with omentum-derived ASCs
(5097 ± 703 IU/L compared with 2787 ± 260 IU/L at 6 h,
P < 0.01, and 11259 ± 1159 IU/L compared with 8141 ±
910 IU/L at 24 h, P < 0.05) (Fig. 2B). In addition, liver
histological staining showed extensive necrosis with in-
flammation and ballooning in the centrolobular region at
6 h after APAP exposure (Fig. 2D2) (histological necrosis
score: 3.8) and extremely severe necrosis (score: 4) at 24 h
after APAP administration (Fig. 2D4). The transplantation
of omentum-derived ASCs decreased the area of cell ne-
crosis (Fig. 2D3, D5) and significantly attenuated the
histological necrosis score severity (2.5 at both 6 and 24 h,
P < 0.01, Fig. 2C). These results showed that omentum-
derived ASCs have therapeutic effects on APAP-induced
liver toxicity.
Omentum ASC transplantation prevents GSH depletion
and enhances antioxidant enzyme activity
Next, we studied whether the hepatoprotective effect of
omentum-derived ASCs was associated with antioxidant
activity in APAP-induced liver injury. The GSH levels dra-
matically declined after 6 h of APAP exposure, indicating
that the high oxidative stress was induced after APAP in-
jection. However, the depletion of the liver GSH content
significantly improved 6 h after omentum-derived ASC
transplantation, with higher hepatic GSH content than the
content after APAP administration (P < 0.01) (Fig. 3a).
Moreover, APAP overdose caused oxidative stress that
resulted from an imbalance between oxidant generation
and antioxidant defense. Transplantation with omentum-
derived ASCs significantly increased hepatic antioxidant
enzyme activity. SOD activity was increased by 47 %, GPx
activity was enhanced by 28 %, and catalase activity in-
creased by as much as 12 % compared with the activity
levels in the APAP administered group (Fig. 3b–d). Fur-
thermore, Nrf2 is a master regulator of the transcriptional
activation of genes related to the antioxidant defense sys-
tem, and it controls downstream heme oxygenase-1 (HO-
1) expression. We examined Nrf2, HO-1 and NADPH
quinone oxidoreductase 1 (NQO1) gene expression by Q-
PCR and found that these gene expression significantly in-
creased in the omentum-derived ASC group compared
with the APAP-treated group (Fig. 3e–g). These results
suggested that omentum-derived ASCs protect against
Table 1 Primer sequences



















Primers used in quantitative PCR
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APAP toxicity by enhancing antioxidant defense and redu-
cing GSH depletion.
Omentum-derived ASCs affect the metabolism of APAP
We further studied whether the transplantation of
omentum-derived ASCs affected APAP metabolism.
CYP2E1 is an important cytochrome enzyme that is re-
sponsible for the toxic metabolism of APAP to NAPQI,
which depletes GSH. Additionally, CYP2E1 binds to vital
proteins and causes cell death. Immunohistology revealed
that CYP2E1 was strongly expressed 6 h after APAP treat-
ment but only weakly expressed in the omentum-derived-
ASC-treated group (Fig. 2E). The transplantation of
omentum-derived ASCs markedly reduced the expression
of CYP2E1 protein 24 h after APAP treatment (Fig. 4f).
Beside, other forms of cytochrome P450 expression were
revealed that CYP1A2 protein was decreased significantly
at 24 h (Fig. 4f) and Cyp2a5 gene level was reduced sig-
nificantly at 6 h after omentum-derived ASCs transplant-
ation (Fig. 4g). Oxidative stress induces lipid peroxidation
to produce 4-HNE, and 4-HNE is considered a biomarker
of lipid peroxidation. After 24 h of APAP exposure, the
liver sections showed increased 4-HNE-positive cells that
were localized in the centrilobular area (Fig. 2F4). Immu-
nohistology and western blots showed that the 4-HNE ex-
pression in the omentum-derived ASC transplantation
Fig. 1 Phenotype and differentiation capacity of omentum-derived ASCs. (a) Omentum-derived ASCs were stained with surface markers and analyzed by
flow cytometry. (b) The cell differentiation ability was assessed in omentum-derived ASCs that were cultured under various differentiation conditions. B1:
adipogenic differentiation (Oil Red O staining); B2: hepatogenic differentiation (periodic acid-Schiff staining); and B3: osteogenic differentiation (alizarin
staining), 200x
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group was lower than that of the APAP group (Figs. 2F4
and 4f). Moreover, APAP overdose caused nitrotyrosine
protein formation in the centrilobular region. Protein nitra-
tion, which is a marker of oxidative stress that is caused by
peroxynitrite, occurs through the rapid reaction of super-
oxide with nitric oxide. Nitrotyrosine protein increased
strongly in the centrilobular regions 24 h after APAP injec-
tion but was only weakly expressed in the omentum-
derived ASC treatment group (Figs. 2G and 4f). Therefore,
the transplantation of omentum-derived ASCs suppressed
cytochrome P450 activity by decreasing the production of
the toxic APAP metabolite NAPQI. This response led to
Fig. 2 Omentum-derived ASCs prevent APAP-induced hepatotoxicity. Omentum-derived ASCs were transplanted into mice with acute liver failure
that had been induced by APAP (600 mg/kg, i.p.). Mouse omentum-derived ASC transplantation significantly improved the survival rate for mice
with acute liver failure (n = 20 in each group) (a) and significantly decreased the liver damage caused by APAP according to both the serum liver
enzyme (GPT) levels (b) and the tissue histological grade (c). The data are expressed as the means ± SEM, n≥ 5, *P < 0.05, **P < 0.01. (D) H&E staining
shows that APAP caused severe centrilobular necrosis (D2: 6 h after APAP; D4: 24 h after APAP). Omentum-derived ASC transplantation decreased the
severity of liver damage caused by APAP (D3: 6 h after APAP + omentum-derived ASC treatment; D5: 24 h after APAP + omentum-derived
ASC treatment). Immunohistological staining shows that APAP treatment induced the expression of CYP2E1 (E2-E5), 4-HNE (F2-F5), and NTR
(G2-G5), which were suppressed after omentum-derived ASC transplantation. CYP2E1: cytochrome P450 2E1; 4-HNE: 4-hydroxynonenal; and
NTR: nitrotyrosine. Magnification, 200x
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Fig. 3 Omentum-derived ASCs protect the liver against APAP-induced injury via the increased activity of antioxidant enzymes. Liver tissue samples
were collected 6 h after omentum-derived ASC transplantation. The lysate was assessed for GSH content and antioxidant enzyme activity. The (a) GSH
content and antioxidant enzyme activities of (b) SOD, (c) GPx, and (d) catalase increased significantly after omentum-derived ASC transplantation. The
expression of (e) HO-1, (f) Nrf2 and (g) NQO1 are increased significantly 24 h after omentum-derived ASC transplantation. The data are expressed as
the means ± SEM, n≥ 5, *P < 0.05, **P < 0.01
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the decreased consumption of GSH and decreased oxida-
tive stress, protecting hepatocytes from APAP-induced cell
damage.
Omentum ASCs attenuate MAPK signal activation and the
inflammatory response in vivo
Accumulated toxic APAP metabolites can generate oxi-
dative stress and subsequently activate mitogen-activated
protein kinases (MAPK) signaling and inflammatory cyto-
kine production to induce further cell damage. The gene
expression of the pro-inflammatory cytokines IL-1α
(Fig. 4a) and IL-1β (Fig. 4b) decreased significantly in the
omentum-derived ASC group 6 h after APAP injection.
The gene expression of the anti-inflammatory cytokines
IL-6 (Fig. 4c) and IL-10 (Fig. 4d) increased significantly in
the omentum-derived ASC group 6 h after APAP injection.
Fig. 4 Omentum-derived ASC transplantation attenuated APAP-induced inflammation, and MAPK signaling activation. Omentum-derived ASC
transplantation decreased the expression of the pro-inflammatory cytokines (a) IL-1α and (b) IL-1β and increased the expression of anti-inflammatory
cytokines (c) IL-6 and (d) IL-10 to a significant degree. Omentum-derived ASC transplantation suppressed the MAPK signaling pathway activation
induced by APAP treatment. e Liver tissue was collected 6 h after omentum-derived ASC transplantation into APAP-treated mice and used for RT-PCR
(a, b, c and d) and western blot (e) analysis. (f) CYP 450 2E1, CYP 450 1A2, NTR, and 4-HNE protein expression by western blot analysis. (g) CYP2A5
gene expression by RT-PCR. The data are expressed as the means ± SEM, n≥ 5, **P < 0.01, ***P < 0.001
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MAPK signaling pathways play critical roles in mediating
APAP hepatotoxicity. The phosphorylation of the ERK
and JNK proteins (pERK and pJNK) increased 6 h after
APAP injection, but this response was suppressed in the
omentum-derived ASC group (Fig. 4e). These results
showed that the protective effect of omentum-derived
ASCs against APAP toxicity also suppressed MAPK acti-
vation and attenuated the inflammatory response.
Hepatoprotective effect of omentum ASCs on APAP-
induced damage in isolated hepatocytes
To clarify whether the omentum-derived ASCs directly
protect against APAP toxicity in primary mouse hepato-
cytes, we isolated primary hepatocytes and exposed them
to various APAP concentrations to measure their ROS
production by CellROX assay. The ROS generation was
dose dependent and increased significantly in response
to 15 and 20 mM of APAP exposure (Fig. 5a). The via-
bility of the hepatocytes decreased significantly to 70 %
of the pretreatment level after treating with 10 mM
APAP, and it decreased dramatically to 35 % after treat-
ing with 15 mM APAP (Fig. 5b). We chose to administer
15 mM APAP during the subsequent in vitro co-culture
mechanistic studies because no differences in viability
were observed in omentum-derived ASCs at this APAP
concentration (data not shown). The viability of APAP-
treated hepatocytes increased significantly after co-culture
with omentum-derived ASCs compared with APAP ex-
posure alone at 24 h (52 % compared with 35 % at 15 mM
APAP, P < 0.001). The LDH release after APAP treatment
was higher than that of the control hepatocytes (P <
0.001), but it was reduced in the omentum-derived ASC
co-culture group (P < 0.05) (Fig. 5c). These results show
that omentum-derived ASCs significantly increased the
viability and markedly reduced the LDH release in hepato-
cytes that were treated with APAP. NAPQI is a toxic me-
tabolite of APAP that is able to cause GSH depletion by
covalently binding to hepatic GSH. The GSH content of
omentum-derived ASCs co-cultured hepatocytes in-
creased to 5.4 μg/ml (compared with 4.7 μg/ml in normal
hepatocytes, P < 0.05). The GSH content in cultured hepa-
tocytes decreased to 1.67 μg/ml after APAP exposure but
then increased to 2.78 μg/ml in APAP-treated hepatocytes
that were co-cultured with omentum-derived ASCs (P <
0.01) (Fig. 5d). These results show that omentum-derived
ASCs increased the hepatic GSH content, which could at-
tenuate toxic NAPQI formation. Furthermore, the activity
of antioxidant enzymes in hepatocytes significantly de-
creased after APAP exposure for 24 h (catalase activity:
64.9 %, Fig. 5f and GPx activity: 53.9 %, Fig. 5g). The activ-
ity of antioxidant enzymes in APAP-treated hepatocytes
increased significantly after co-culture with omentum-
derived ASCs (SOD and catalase activity: 10 %, P < 0.05
and GPx activity: 20 %, P < 0.05). Finally, we studied
whether MAPK pathways were involved in the protec-
tion of omentum-derived ASCs against APAP hepato-
toxicity. The levels of JNK and ERK phosphoproteins
were significantly increased in hepatocytes at 12 h and
24 h after APAP exposure but were suppressed after
co-culture with omentum-derived ASCs (Fig. 5h, i).
Therefore, the activation of the JNK/ERK pathway by
APAP metabolites was diminished by omentum-derived
ASC treatment.
Discussion
In this study, we investigated whether omentum-derived
ASC therapy could rescue APAP-induced acute liver fail-
ure. We found that the transplantation of omentum-
derived ASCs significantly improved the survival of mice
with APAP-induced acute liver failure. Additionally, we
showed that omentum-derived ASCs scavenged ROS
through the upregulation of Nrf2 activation, and they
decreased toxic peroxynitrite formation by suppressing
cytochrome P450 expression. Finally, omentum-derived
ASCs attenuated the subsequent inflammatory response
and the activation of MAPK signaling to protect against
APAP-induced hepatocyte death (Fig. 6). We deduce
that mechanism that mediate the protectives effect of
omentum-derived ASCs are immunosuppressing, which
downregulation of proinflammatory cytokines (IL-1α,
IL-1β) and upregulation of anti-inflammatory (IL-6, IL-
10). And, paracrine properties of MSC to improve liver
function and guide MSCs homes to injury site mediated
by their expression of growth factors and cytokines. It is
worth nothing that protective effects of MSCs are antioxi-
dant. Based on our observation, omentum-derived ASCs
are highly resistant to APAP-induced death and scavenge
ROS, increase intracellular GSH levels and antioxidant en-
zyme activity mediated by Nrf2 expression.
APAP toxicity is mediated by cytochrome P450 metabol-
ism to NAPQI, which causes hepatic GSH depletion, lipid
peroxidation, and nitrotyrosine protein accumulation lead-
ing to cell death. It has been suggested that an effective
strategy for preventing APAP hepatotoxicity is to inhibit
CYP2E1 activity [12, 13]. Lee also showed that CYP2E1-
knockout mice were less susceptible to APAP toxicity [14,
15]. Our immunohistology results showed that CYP2E1 ex-
pression decreased significantly in the omentum-derived-
ASC-treated group. In addition, CYP1A2 and CYP2A5
have metabolic activity toward APAP. We also found both
CYP1A2 and CYP2A5 were inhibited after omentum-
derived ASCs transplantation. Therefore, suppression of
cytochrome P450 activity contributed to the hepatoprotec-
tive effect of omentum-derived ASCs. APAP-induced hep-
atotoxicity consists of a metabolic phase and an oxidative
phase. During the metabolic phase, the metabolite NAPQI
causes GSH depletion and covalent binding to liver pro-
teins, which triggers cell dysfunction and generates ROS
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Fig. 5 Omentum-derived ASCs protect primary isolated hepatocytes from APAP-induced toxicity. a Primary isolated hepatocytes were exposed to
various concentrations of APAP for 24 h, and the intracellular ROS levels were measured by Cell ROX assay. The intracellular ROS levels increased
significantly after APAP treatments at concentrations that exceeded 15 mM (a). Hepatocyte viability decreased significantly after treatment with
the same APAP concentration (b). We chose 15 mM APAP for the subsequent in vitro studies. Hepatocytes were treated with APAP and co-cultured
with/without omentum-derived ASCs in a transwell co-culture system. The viability of the APAP-treated hepatocytes improved significantly after 24 h
of co-culture with omentum-derived ASCs, as shown by the MTT assay (b). LDH that was released into the culture medium decreased significantly after
co-culture with omentum-derived ASCs (c). The GSH content of APAP-treated hepatocytes increased significantly after 24 h of co-culture with
omentum-derived ASCs (d). The antioxidant enzyme (SOD, catalase, and GPx) activity also increased significantly after co-culture with omentum-derived
ASCs (e, f, g). The expression of phosphorylated MAPK signaling pathway proteins (ERK/JNK) in APAP-treated hepatocytes decreased significantly after
24 h of co-culture with omentum-derived ASCs (h, i). The quantification of the phosphorylated proteins in each lane was normalized to the total protein
levels. The data are expressed as the means ± SEM, n≥ 5, *P< 0.05, **P< 0.01, and ***P< 0.001
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that induce lipid peroxidation and interfere with antioxi-
dant defense mechanisms during the oxidative phase [16].
Nrf2 is a transcription factor that regulates the expression
of phase II enzymes and transports protein metabolites to
protect cells against oxidative stress [17]. Chan et al. [18]
demonstrated that Nrf2−/− mice are more sensitive to
APAP toxicity and have lower levels of liver GSH. MSCs
can also act as an antioxidant to regulate the oxidative
microenvironment [19–21]. In a recent study [7, 22] on
MSC antioxidant ability, MSC transplantation reportedly
reduced oxidative stress by supplying GSH in the liver of
animals with APAP overdose. Thus, our results showing
protective effects were consistent with their finding. Fur-
thermore, key findings in the current study include that
omentum-derived ASCs were essential to upregulating
Nrf2 and that they inhibited cytochrome P450 expression
to protect cells against APAP toxicity. It is possible that
MSCs express CD44 markers, which reportedly activate
the Nrf2 pathway to protect against APAP toxicity [16, 23,
24]. We successfully isolated ASCs from the omentum
and demonstrated their MSC properties, and the results
revealed that the omentum-derived ASCs significantly in-
creased Nrf2 expression to activate antioxidant enzyme
activity (SOD, GPx, and catalase) and cellular GSH synthe-
sis. Omentum-derived ASCs were able to scavenge excess
ROS by activating the Nrf2 pathway, leading to increased
GSH synthesis and enhanced antioxidant defense. N-
acetylcysteine (NAC) protects against APAP hepatotoxicity
by increasing the intracellular GSH content that is available
to conjugate to NAPQI in animal experiments [25], indi-
cating a role for these cells as a potential therapy for
APAP-induced acute liver failure in clinical practice [26].
However, the limitations of NAC therapy include a short
therapeutic time window, adverse gastrointestinal effects
and an anaphylactoid reaction [1]. Consequently, the anti-
oxidative effect of omentum-derived ASCs offers another
therapeutic approach to protect against APAP hepatotox-
icity in clinical practice.
The toxic metabolites of APAP damage hepatocytes and
cause the release of inflammatory mediators, particularly
IL-1α and IL-1β [27], which induce further cell damage.
MSCs also exhibit immunomodulatory properties [28, 29].
Our results show that omentum-derived ASCs signifi-
cantly suppressed the release of pro-inflammatory cyto-
kines (IL-1α and IL-1β) and increased the release of
anti-inflammatory cytokines (IL-6 and IL-10). The
immunomodulation effect of omentum-derived ASCs
also contributed to the efficiency of protection against
APAP-induced hepatotoxicity. These inflammatory me-
diators are regulated by MAPK signal transduction,
which plays a central role in cell survival, proliferation,
apoptosis, and inflammation [30]. One potential anti-
inflammatory therapeutic strategy is to suppress the acti-
vation of the MAPK to reduce pro-inflammatory cytokine
release and promote anti-inflammatory cytokine produc-
tion [7, 31]. Our results showed that omentum-derived
ASCs also have an immunomodulatory effect by regulat-
ing the MAPK pathway.
Conclusions
In conclusion, our results show that ASCs can be ob-
tained from omentum adipose tissue, and they possess
antioxidant and anti-inflammatory properties that pro-
vide protection against APAP-induced hepatotoxicity.
Thus, omentum-derived ASCs have potential as an alter-
native source for cell therapy, and may be is an effective
therapeutic strategy for APAP-induced liver failure in
clinical practice.
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